These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39362023)

  • 1. Stimuli-responsive prodrugs with self-immolative linker for improved cancer therapy.
    Xu W; Jia A; Lei Z; Wang J; Jiang H; Wang S; Wang Q
    Eur J Med Chem; 2024 Dec; 279():116928. PubMed ID: 39362023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment.
    Edupuganti VVSR; Tyndall JDATDA; Gamble AB
    Recent Pat Anticancer Drug Discov; 2021; 16(4):479-497. PubMed ID: 33966624
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Lee VEY; Lim ZC; Chew SL; Ang WH
    Inorg Chem; 2021 Feb; 60(3):1823-1831. PubMed ID: 33464875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast Cyclization of a Proline-Derived Self-Immolative Spacer Improves the Efficacy of Carbamate Prodrugs.
    Dal Corso A; Borlandelli V; Corno C; Perego P; Belvisi L; Pignataro L; Gennari C
    Angew Chem Int Ed Engl; 2020 Mar; 59(10):4176-4181. PubMed ID: 31881115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives About Self-Immolative Drug Delivery Systems.
    Gonzaga RV; do Nascimento LA; Santos SS; Machado Sanches BA; Giarolla J; Ferreira EI
    J Pharm Sci; 2020 Nov; 109(11):3262-3281. PubMed ID: 32860799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma-targeted delivery system (part 1): design, synthesis and evaluation of releasable disulfide drug by glutathione.
    El Aissi R; Chezal JM; Tarrit S; Chavignon O; Moreau E
    Eur J Med Chem; 2015 Aug; 101():668-80. PubMed ID: 26210505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update.
    Tranoy-Opalinski I; Legigan T; Barat R; Clarhaut J; Thomas M; Renoux B; Papot S
    Eur J Med Chem; 2014 Mar; 74():302-13. PubMed ID: 24480360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended scaffold glucuronides: en route to the universal synthesis of O-aryl glucuronide prodrugs.
    Walther R; Jarlstad Olesen MT; Zelikin AN
    Org Biomol Chem; 2019 Jul; 17(29):6970-6974. PubMed ID: 31290904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer prodrugs: an overview of major strategies and recent developments.
    Arpicco S; Dosio F; Stella B; Cattel L
    Curr Top Med Chem; 2011; 11(18):2346-81. PubMed ID: 21671864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esterase-Responsive Fluorogenic Prodrugs of Aldose Reductase Inhibitor Epalrestat: An Innovative Strategy toward Enhanced Anticancer Activity.
    Misra R; Barman P; Bhabak KP
    ACS Appl Bio Mater; 2024 Oct; 7(10):6542-6553. PubMed ID: 39146213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new cyclopamine glucuronide prodrug with improved kinetics of drug release.
    Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S
    Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy.
    Liu P; Xu J; Yan D; Zhang P; Zeng F; Li B; Wu S
    Chem Commun (Camb); 2015 Jun; 51(46):9567-70. PubMed ID: 25971544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular Enzyme-Responsive Profluorophore and Prodrug Nanoparticles for Tumor-Specific Imaging and Precise Chemotherapy.
    Pei Q; Lu S; Zhou J; Jiang B; Li C; Xie Z; Jing X
    ACS Appl Mater Interfaces; 2021 Dec; 13(50):59708-59719. PubMed ID: 34879654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigen.
    Wu X; Hu L
    Bioorg Med Chem; 2016 Jun; 24(12):2697-706. PubMed ID: 27156193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing SN38 prodrug delivery using a self-immolative linker and endogenous albumin transport.
    Jiang X; Zhu L; Wei Q; Lu W; Yu J; Zhu S
    J Control Release; 2024 May; 369():622-629. PubMed ID: 38604383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-sensitive prodrugs; a promising approach for site-specific and targeted drug release.
    Nazli A; Irshad Khan MZ; Rácz Á; Béni S
    Eur J Med Chem; 2024 Oct; 276():116699. PubMed ID: 39089000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancements in platinum-based anticancer drug development: A comprehensive review of strategies, discoveries, and future perspectives.
    Sahoo D; Deb P; Basu T; Bardhan S; Patra S; Sukul PK
    Bioorg Med Chem; 2024 Oct; 112():117894. PubMed ID: 39214013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a Thiol-Responsive, Traceless Prodrug with Rapid Self-Immolation for Cancer Chemotherapy.
    Liu G; Jiang Z; Lovell JF; Zhang L; Zhang Y
    ACS Appl Bio Mater; 2021 Jun; 4(6):4982-4989. PubMed ID: 35007046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.